PHK
NXTM

Point72 Hong Kong’s NxStage Medical Inc. NXTM Stock Holding History

Point72 Hong Kong’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-165
Closed -$4K – 1184
2017
Q2 		$4K Buy
+165
New +$4.08K ﹤0.01% 605
2017
Q1 		– Sell
-533
Closed -$14K – 1134
2016
Q4 		$14K Buy
+533
New +$13.2K 0.01% 605

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 Hong Kong's NXTM Position: Q3 2017 in Review

Point72 Hong Kong sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 165 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in NXTM in Q4 2016 and held it in 2 quarters. The position peaked at $14K in Q4 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Point72 Hong Kong reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Point72 Hong Kong sold 165 NxStage Medical Inc. shares in Q3 2017, an estimated $4K.
  • Point72 Hong Kong first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 2 quarters.
  • Point72 Hong Kong's NxStage Medical Inc. position peaked at $14K in Q4 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Point72 Hong Kong's 13F filing for Q3 2017, filed 14 Nov 2017.